Relmada Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$2.60(as of Oct 2, 3:58 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Relmada Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$2.60
Ticker SymbolRLMD
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees17
CountyUSA
Market Cap$71.7M
EBIDTA-161.2M
10-Day Moving Average1.87
P/E Ratio-1.30
20-Day Moving Average1.73
Forward P/E Ratio0.00
50-Day Moving Average1.13
Earnings per Share-2.36
200-Day Moving Average0.61
Profit Margin-Infinity%
RSI85.21
Shares Outstanding33.2M
ATR0.23
52-Week High3.98
Volume919,411
52-Week Low0.24
Most Recent Support Level1.53
Book Value15.9M
Most Recent Resistance Level1.75
P/B Ratio5.54
Upper Keltner2.24
P/S RatioInfinity
Lower Keltner1.22
Debt-to-Equity Ratio2.24
Next Earnings Date11/06/2025
Cash Surplus-3.8M
Next Ex-Dividend DateUnknown

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.

Relmada Therapeutics Inc In Our Stock Scanner

As of Oct 03, 2025
example chart graphic
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Discounted Stocks with Earnings GrowthScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.